CLINICAL_TRIALS
research
· 2011-12-12
Clinical Trial Update: The Role of the EKG in Anticancer Drug Development
Summary
This update outlines the role of electrocardiography (EKG) in anticancer drug development and how cardiac monitoring can inform safety assessments in trials.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Status: COMPLETED